GBI International
NEW

Taiwan’s Top 12 Sleep Tech Innovators You Need to Know!
GBI International
NEW

From Industrial IoT to Digital Sleep Health!

GBI International
NEW

Taiwan’s Sleep Tech Shocks NAVER & Delightroom!

GBI International
GBIHighlights

Bringing mRNA Innovation to Taiwan: Meet the Leader Driving the Future of Medicine!

2024-12-30/GlobalBio & Investment
InSeptember2022,globalbiotechgiantModernamarkedamilestonebyestablishingitsTaiwansubsidiary,namingJoyceLee,aseasonedpharmaceuticalexecutive,asitsGeneralManager.TaiwannowjoinsModerna’stop10strateg...
GBI International
GBIHighlights

Trailblazer in Regenerative Medicine: Meet Taiwan’s Pioneer in Parkinson’s Stem Cell Therapy!

2024-12-28/GlobalBio & Investment
Dr.Shinn-ZongLin,DirectorofHualienTzuChiMedicalCenter,hasmadehistoryasthefirstinTaiwantotransplantembryonicneuralstemcellsintopatientswithParkinson’sdiseaseandthefirstgloballytouseautologousperi...
GBI International
GBIHighlights

No Needles? Meet Taiwan’s Trailblazer in Nasal Spray Protein Drugs!

2024-12-26/GlobalBio & Investment
Forover20years,Dr.Yu-ShenHsu,OxfordPh.D.andCEOofAdvageneBiopharma(6709),haschampionedthedevelopmentofLTh(αK),agroundbreakingmucosalimmunomodulatingprotein.Fromasthmaandallergicrhinitistofluvacci...
GBI International
GBIHighlights

Japan’s Regenerative Medicine: A Decade In, What’s Holding It Back?

2024-12-24/GlobalBio & Investment
Sincethe2013RegenerativeMedicineLawstookeffect,Japanhaspouredresourcesintoadvancingregenerativetherapies.Yet,noJapaneseproducthassuccessfullylaunchedoverseas,sparkingnationaldebateovertheindustry'...
GBI International
GBIHighlights

A Legacy in Mitochondrial Medicine: 35 Years of Groundbreaking Research!

2024-12-22/GlobalBio & Investment
Joinusonajourneythrough35yearsofpioneeringmitochondrialresearchwithDr.WeiYau-Huei,themanknownasTaiwan's"FatherofMitochondria."AsthefoundingpresidentofMackayMedicalCollegeandthecurrentdis...
GBI International
GBIHighlights

The Red Supply Chain Threatens Taiwan's Medical Devices!

2024-12-20/GlobalBio & Investment
Taiwan'smedicaldeviceindustryisfacingincreasingpressurefromChina'sredsupplychain.WiththerisingimportvalueofChinese-mademedicaldevices,Taiwan'smarketisatriskofbeingovertakenbylower-costcomp...
GBI International
GBIHighlights

"Innovative Operating Rooms" – Taiwan’s Surgical Tech Armada Sets Sail!

2024-12-18/GlobalBio & Investment
Astheworldemergesfromthepandemic,surgeriesareontherise,withTaiwanaveragingover7,000surgeriesperdayin2023!Thissurgeisdrivingarevolutioninsurgicaltechnologies,includingsmartimaging,cardiovasculardevices...
GBI International
GBIHighlights

The Future of Surgery is Robotic!

2024-12-16/GlobalBio & Investment
ThedaVinciSurgicalSystemhasrevolutionizedmodernmedicine,pavingthewayforsurgicalrobotsacrossdiversefieldslikeorthopedics,neurosurgery,vascularinterventions,andendoscopy.LeadingthischargeisIntuitiveSurg...
GBI International
GBIHighlights

Smart Hospitals Take the Field: Meet Taiwan's All-Star Players in MedTech!

2024-12-14/GlobalBio & Investment
Taiwan’ssmarthealthcarejourneyhasshiftedfromconcepttocommercialization,transformingthelandscapeofmodernmedicine.AccordingtoGlobalbio'ssurveyof20leadingmedicalcenters,thetopfocusareasare: Art...
GBI International
NGS WGS WES Genomics AI

KimForest & Essense AI Launch the Whole Genome AI Platform!

2024-12-13/GlobalBio & Investment
OnDecember7,KimForest(StockCode:6645.TWO)anditssubsidiaryEssenseAIhostedaforumtochampionthefutureofprecisionhealthmanagement.Duringtheevent,EssenseAI'sGeneralManager,DanielHuang,proudlyannouncedth...
GBI International
GBIHighlights

A New "Vision" in Eye Care: Meet the Doctor Transforming Ophthalmology!

2024-12-12/GlobalBio & Investment
Dr.Ta-ChingChen,AssociateProfessoratNTUHospital’sDepartmentofOphthalmology,isredefininghowwetacklecomplexeyediseases.Aftercompletingadvancedtrainingin2017atMassachusettsEyeandEar(MEE)—aglo...
GBI International
GBIHighlights

Taiwan and Japan Lead the Way in iPSC Regenerative Medicine!

2024-12-08/GlobalBio & Investment
InducedPluripotentStemCell(iPSC)technologyisattheforefrontofregenerativemedicine,buttheindustryistacklingkeychallenges:teratomaformation,manufacturingcomplexity,geneticheterogeneity,cellimmaturity,and...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：service@gbimonthly.com
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務